Jason P. Kirkness, Ph.D.

Media Releases

Get to know Jason P. Kirkness, who works in Woodland Hills, California.

Jason is a clinical science executive and physiologist with leadership in novel medical device research, development and commercialization. Joining 4DMedical in June 2020, his training, experience, and passion has positioned him to the role of Senior Vice President of Medical and Clinical Affairs. 

One of the most critical health challenges over the next decade will be to access, manage, and utilize big data in order to discover sustainable improvements in quality of life. This effort requires tremendous coordination, teamwork, innovation, and creativity. The focus of Jason’s career has been on novel technology, biological instrumentation, practice change, and implementation of diagnostic and therapeutics for chronic diseases in children and adults. 

4DMedical (formerly known as 4Dx) is a global medical technology company aiming to change the outcome for patients with lung disease by revolutionizing respiratory imaging and ventilation analysis.

With offices in Melbourne, Australia and Los Angeles, California, 4D Medical has successfully proven and patented its XV Technology through years of studies and trials, completed by some of the most talented minds in medical technology.

“Our mission is to improve global health by providing unique and non-invasive imaging technologies that enable unprecedented insight into pulmonary functioning, critical in the analysis and management of respiratory diseases” as stated on the company’s website. 

Initially educated at Western Sydney University, Jason graduated with his Bachelor’s degree in Biology and his Bachelor’s degree in Exercise and Respiratory Physiology (1st class honors) in 1996 and 1997, respectively. 

Furthering his education, he completed his Doctor of Philosophy degree at the University of Sydney in 2003, and his post-doctoral fellowship at The Johns Hopkins University School of Medicine in 2006.

With over 20 years training and experience in pulmonary physiology and sleep medicine, Jason was previously an Assistant Professor of Medicine at Johns Hopkins School of Medicine, where his areas of investigation were novel technology, biological instrumentation, diagnostics, and therapies for chronic diseases. He has received research funding from the National Institutes of Health (NIH), the National Science Foundation (NSF), the American Heart Foundation, and the Australian National Health and Medical Research Council (NHMRC), among others. 

An active, long-standing and contributing member of the American Thoracic Society (ATS), Jason is on the ATS Drug Device Discovery and Development Committee. He is also an active member of the American College of Chest Physicians, the American Association of Respiratory Care, and the Society of Critical Care Medicine. 

All in all, Jason strives to optimize healthcare resource allocation, improve patient outcomes, and evolve the business of medicine. He has authored more than 70 peer reviewed publications, book chapters and editorials, as well as patents in respiratory medicine.

Among his various accolades include I-Corps Technology Award (2016), American Heart Association National Career Development Award (2012), Asia Pacific Society for Respirology Career Development Award (2008), John Read Prize (2007, 1997), to name a few.

Recommended Articles

• Pulmonary Rehabilitation for Patients with COPD

  Patients who are diagnosed with chronic obstructive pulmonary disease (COPD) should expect mucus production that is tenacious, long-term coughing, and extreme fatigue. The main concern with COPD is if permanent scars have developed in the lungs. If scarring does occur, the condition cannot be cured...

• Community-Acquired Pneumonia: Causes, Symptoms, and Management

  Community-acquired pneumonia (CAP) refers to pneumonia that develops in people with very less or no contact with any medical setting such as a hospital or clinic. Most of the time, the people who are infected with CAP are healthy individuals.Background of the DiseaseFour million cases...

• Australian Teen's Experience Living with Cystic Fibrosis

  Every day when Kate Daly, a teen from Canberra, joins her friends for lunch at Radford College, she has to open a small package that her mother, Ellen, tapes to her lunchbox.Inside the package is Kate's daily dose of digestive enzymes. Kate has to take these enzymes with every single meal. Her mom...

• What Is Orthopnea?

  OrthopneaOrthopnea is a condition that causes breathing difficulties when an individual is lying down. It usually happens at night when the person is going to sleep. People with orthopnea usually experience tightness in the chest and being oxygen-deficit. The shortness of breath is due to lying down...

• What Are the Signs and Symptoms of AIDS?

  Acquired immunodeficiency syndrome, or AIDS, is a serious secondary immunodeficiency disorder. AIDS is caused by human immunodeficiency virus (HIV). There is progressive destruction of cell-mediated (T cell) immunity. Also, both conditions are characterized by subsequent effects on humoral immunity...

• Is Ibuprofen the Secret to Cystic Fibrosis Treatment?

  Scientists say yes. The drug that works wonders for so many other everyday ailments could be a key component in the future treatments of cystic fibrosis patients. It’s hard to imagine that a drug found in nearly everyone's medicine cabinet could be a crucial component in the treatment of cystic...